Literature DB >> 1915483

Spontaneous hyphaema in childhood.

I A Murdoch1, R Dos Anjos, J M Parsons, D M Calver.   

Abstract

Between January 1987 and September 1989 three children presented to the childrens' casualty department with spontaneous hyphaema. Physical examination and haematological investigations were sufficient to determine their cause in two cases (sickle cell disease and acute lymphoblastic leukaemia). In the third child an ophthalmological examination under general anaesthesia revealed a granulomatous lesion of the iris consistent with the diagnosis of juvenile xanthogranuloma.

Entities:  

Mesh:

Year:  1991        PMID: 1915483     DOI: 10.1007/bf01958762

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  MANAGEMENT OF JUVENILE XANTHOGRANULOMA OF THE IRIS.

Authors:  J D GASS
Journal:  Arch Ophthalmol       Date:  1964-03

2.  Spontaneous hyphema in infancy and childhood.

Authors:  G M HOWARD
Journal:  Arch Ophthalmol       Date:  1962-11

3.  Medical and surgical management of spontaneous hyphaema secondary to immune thrombocytopenia.

Authors:  C J McDonald; A Raafat; M J Mills; J A Rumble
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

4.  [The ocular manifestations of blood diseases].

Authors:  J M Massa; N De Vloo; L Jamotton
Journal:  Bull Soc Belge Ophtalmol       Date:  1966

5.  Retinoblastoma presenting as a total hyphema.

Authors:  T Appelboom; F Durso
Journal:  Ann Ophthalmol       Date:  1985-08

6.  Traumatic hyphema in children.

Authors:  P J Agapitos; L P Noel; W N Clarke
Journal:  Ophthalmology       Date:  1987-10       Impact factor: 12.079

7.  Sickle cell hyphema with secondary glaucoma in a non-black patient.

Authors:  M J Greenwald; T M Crowley
Journal:  Ophthalmic Surg       Date:  1985-03
  7 in total
  1 in total

1.  Intravitreal bevacizumab (Avastin) associated with secondary hyphaema in a case of proliferative sickle cell retinopathy.

Authors:  Olufemi Emmanuel Babalola
Journal:  BMJ Case Rep       Date:  2010-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.